-
Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer
Sewnath, CAN., Behrens, LM. & van Egmond, M., 19 Jul 2022, In: Expert Opinion on Biological Therapy. 22, 8, p. 983–995 13 p.Research output: Contribution to journal › Review article › Academic › peer-review
-
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
Behrens, L. M., van den Berg, T. K. & van Egmond, M., 1 Jul 2022, In: Cancers. 14, 14, 3366.Research output: Contribution to journal › Review article › Academic › peer-review
-
Neutrophils as immune effector cells in antibody therapy in cancer
Behrens, L. M., van Egmond, M. & van den Berg, T. K., 2022, (E-pub ahead of print) In: Immunological reviews.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
